Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 9, 2015, Pages 1759-1765

  Hedayati, M T ^a,b   Azimi, Y ^a,b   Droudinia, A ^c   Mousavi, B ^a,b   Khalilian, A ^b   Hedayati, N ^d   Denning, D W ^e,f  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; FUNGUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOMA; ASPERGILLUS FUMIGATUS; CHILD; CHRONIC DISEASE; CORONARY ARTERY THROMBOSIS; COUGHING; DIABETES MELLITUS; FATIGUE; FEMALE; FUNGUS HYPHAE; GRAFT RECIPIENT; HEPATITIS; HUMAN; IRAN; LUNG ASPERGILLOSIS; LUNG LESION; MAJOR CLINICAL STUDY; MALE; PLEURA THICKENING; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS; WEIGHT REDUCTION; BLOOD; BRONCHOSCOPY; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; LUNG TUBERCULOSIS; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PULMONARY ASPERGILLOSIS; SPUTUM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, FUNGAL; ASPERGILLUS FUMIGATUS; BRONCHOSCOPY; CHILD; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IRAN; LUNG; MALE; MIDDLE AGED; PULMONARY ASPERGILLOSIS; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84940437028     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2409-7     Document Type: Article

References (41)

1. Murray CJ, Ortblad KF, Guinovart C et al (2014) Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9947):1005–1070
2. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, Myśliwski A (2006) Comparative analysis of mycobacterial heat shock proteins-induced apoptosis of peripheral blood mononuclear cells in sarcoidosis and tuberculosis. J Clin Immunol 26(3):243–250
3. Yan L, Cui H, Xiao H, Zhang Q (2013) Anergic pulmonary tuberculosis is associated with contraction of the Vd2+T cell population, apoptosis and enhanced inhibitory cytokine production. PLoS One 8(8):e71245
4. Chen JC, Chang YL, Luh SP, Lee JM, Lee YC (1997) Surgical treatment for pulmonary aspergilloma: a 28 year experience. Thorax 52:810–813
5. Denning DW, Riniotis K, Dobrashian R, Sambatakou H (2003) Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 37(Suppl 3):S265–S280
6. Camuset J, Nunes H, Dombret MC et al (2007) Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 131:1435–1441
7. Addrizzo-Harris DJ, Harkin TJ, McGuinness G, Naidich DP, Rom WN (1997) Pulmonary aspergilloma and AIDS. A comparison of HIV-infected and HIV-negative individuals. Chest 111:612–618
8. Smith NL, Denning DW (2011) Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 37(4):865–872
9. Kosmidis C, Denning DW (2015) The clinical spectrum of pulmonary aspergillosis. Thorax 70(3):270–277
10. Ma JE, Yun EY, Kim YE et al (2011) Endobronchial aspergilloma: report of 10 cases and literature review. Yonsei Med J 52(5):787–792
11. Kurhade AM, Deshmukh JM, Fule RP, Chande C, Akulwar S (2002) Mycological and serological study of pulmonary aspergillosis in central India. Indian J Med Microbiol 20(3):141–144
12. Shahid M, Malik A, Bhargava R (2001) Prevalence of Aspergillosis in chronic lung diseases. Indian J Med Microbiol 19(4):201–205
13. Sakarya ME, Özbay B, Yalcinkaya I, Arsalan H, Uzun K, Poykaz N (1998) Aspergillomas in the lung cavities. East J Med 3(1):7–9
14. Ferreira-Da-Cruz MF, Wanke B, Pirmez C, Galvão-Castro B (1988) Aspergillus fumigatus fungus ball in hospitalized patients with chronic pulmonary disease. Usefulness of double immunodiffusion test as a screening procedure. Mem Inst Oswaldo Cruz 83:357–360
15. Iwata H, Miwa T, Takagi K (1990) Tuberculosis sequelae: secondary fungal infections. Kekkaku 65:867–871
16. Raper KB, Fennell DI (1973) The genus Aspergillus. Robert E. Krieger Publishing Company, New York
17. Hope WW, Walsh TJ, Denning DW (2005) The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 43:S207–S238
18. Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB (1997) Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 112:541–548
19. Al-Shair K, Atherton GT, Harris C, Ratcliffe L, Newton PJ, Denning DW (2013) Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis. Clin Infect Dis 57(6):828–835
20. Biswas D, Agarwal S, Sindhwani G, Rawat J (2010) Fungal colonization in patients with chronic respiratory diseases from Himalayan region of India. Ann Clin Microbiol Antimicrob 9:28–35
21. Sivasankari S, Senthamarai S, Anitha C et al (2014) Prevalence of invasive aspergillosis among (PTB) patients in Kanchipuram, India. J Clin Diagn Res 8(3):22–23
22. Shirai M, Hayakawa H, Uchiyama H, Chida K, Nakamura H (2001) Clinical significance of potential pathogenic microorganisms of sputum in patients with pulmonary tuberculosis. Respirology 6(4):311–315
23. Salek Moghaddam A, Soltani Arabshahi SK, Yasami A, Tabatabaie S (2001) Survey of humoral immunity against Aspergillus fumigatus in patients with TB and COPD referred to Iran university hospitals. Pejouhesh 25(3):143–147
24. Nakamoto K, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y (2013) Prognostic factors in 194 patients with chronic necrotizing pulmonary aspergillosis. Intern Med 52(7):727–734
25. Ohba H, Miwa S, Shirai M et al (2012) Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med 106(5):724–729
26. Uffredi ML, Mangiapan G, Cadranel J, Kac G (2003) Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients. Eur J Clin Microbiol Infect Dis 22(8):457–462
27. Kitasato Y, Tao Y, Hoshino T et al (2009) Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis. Respirology 14(5):701–708
28. Fraczek MG, Kirwan MB, Moore CB, Morris J, Denning DW, Richardson MD (2014) Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR. Mycoses 57:69–78
29. Jin E, Wang LM, Li QY, Feng X, Ma SL (2014) Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient: report of a rare case. Infection 42(3):565–568
30. Tashiro T, Izumikawa K, Tashiro M et al (2013) A case series of chronic necrotizing pulmonary aspergillosis and a new proposal. Jpn J Infect Dis 66(4):312–316
31. Pendleton M, Denning DW (2012) Multifocal pulmonary aspergillomas: case series and review. Ann N Y Acad Sci 1272:58–67
32. Denning DW, Pleuvry A, Cole DC (2011) Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 89:864–872
33. [No authors listed] (1968) Aspergillus in persistent lung cavities after tuberculosis. A report from the Research Committee of the British Tuberculosis Association. Tubercle 49:1–11
34. [No authors listed] (1970) Aspergilloma and residual tuberculous cavities—the results of a resurvey. Tubercle 51:227–245
35. Pena TA, Soubani AO, Samavati L (2011) Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature. Lung 189(2):167–172
36. Schweer KE, Bangard C, Hekmat K, Cornely OA (2014) Chronic pulmonary aspergillosis. Mycoses 57(5):257–270
37. Vahid B, Marik P (2007) Fatal massive hemoptysis in a patient on low-dose oral prednisone: chronic necrotizing pulmonary aspergillosis. Respir Care 52:56–58
38. Kokkonouzis I, Athanasopoulos I, Doulgerakis N et al (2011) Fatal hemoptysis due to chronic cavitary pulmonary aspergillosis complicated by nontuberculous mycobacterial tuberculosis. Case Rep Infect Dis 2011:837146
39. Agarwal R, Vishwanath G, Aggarwal AN, Garg M, Gupta D, Chakrabarti A (2013) Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses 56(5):559–570
40. Cadranel J, Philippe B, Hennequin C et al (2012) Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis 31(11):3231–3239
41. Jain LR, Denning DW (2006) The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. J Infect 52:e133–e137